Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Topiramate Tablet, Film Coated
Product Images NDC 72162-2482
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72162-2482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text provides cumulative rates for the time to the first seizure comparing two different dosages of topiramate (50 mg/day and 400 mg/day) in a study involving a total of 470 participants. The graph shows the time in days on the x-axis and the seizure rate on the y-axis. The p-value for the comparison between the two dosages is p=0.0002, indicating a statistically significant difference.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)
Label (Lbl721622482)
This text is a description of a medication with the name Topiramate Tablets, USP 100 mg. It provides storage instructions, dosage information, and cautions for pharmacists to verify prescriptions. The medication is in film-coated tablet form and is intended for prescription use only. It also mentions the name of the company that repackaged the medication and the manufacturing company.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
